ISPOR 2025
Tuesday, May 13 - Friday, May 16
-
Hidden Submitter Control
May 15, 2025, 13:31 PM -
Hidden Submitter Control
Apr 29, 2025, 22:08 PM -
HELMET: A Benchmark Dataset for Evaluating Generative AI in Health Economics and Outcomes Research
Apr 16, 2025, 20:03 PM -
Use of Metamodels in Health Economics to Bypass Complexity and Democratize Modeling
Apr 16, 2025, 20:03 PM -
VBA and R to Automate Health Economic Model Programming
Apr 16, 2025, 20:03 PM -
The Use of Artificial Intelligence in the Development of Economic Models
Apr 16, 2025, 20:03 PM -
Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative
Apr 4, 2025, 22:12 PM -
Navigating Real-World Data (RWD) Complexities: Operational Assessment Strategy to Identify Fit-For-Purpose Data Sources for Real-World Evidence (RWE) Studies With Regulatory Purpose (OASIS)
Apr 4, 2025, 22:12 PM -
Real-World Treatment Patterns of Advanced Melanoma in the United States
Apr 4, 2025, 22:12 PM -
Using Z Codes to Characterize Health and Social Histories in Commercially Insured Non-Hodgkin Lymphoma Patients: Insights from Real-World Data
Apr 4, 2025, 22:12 PM -
Are Pediatric Trials Including More Patient-Centered Outcomes?
Mar 27, 2025, 23:05 PM -
Integrating Patient-Reported Outcomes in Clinical Care - Opportunities and Roadblocks From the Patient Perspective: A Scoping Review
Mar 27, 2025, 23:05 PM -
Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma
Mar 27, 2025, 23:05 PM -
Introduction of Distress Thermometer (DT) Screening in the US Community Oncology Setting: A Retrospective Study of Electronic Health Records (EHR) Integration
Mar 27, 2025, 23:05 PM -
Trial-Based Economic Evaluation of the BrainACT Study: Acceptance and Commitment Therapy for Anxiety and/or Depressive Symptoms After Acquired Brain Injury in the Netherlands
Mar 27, 2025, 23:05 PM -
Cost-Effectiveness of Transthyretin Stabilizing Agents for the Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Mar 27, 2025, 23:05 PM -
Cost-Effectiveness Analysis of Second-Generation Antipsychotic Long-Acting Injectables in Patients with Schizophrenia in the United States
Mar 27, 2025, 23:05 PM -
Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada
Mar 27, 2025, 23:05 PM -
Frequency of ICER Miscalculation and Misinterpretation in Published Cost-Effectiveness Analysis Comparing More Than Two Alternatives
Mar 27, 2025, 21:40 PM -
Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)
Mar 27, 2025, 21:40 PM